Aimei Health Technology Co., Ltd
AFJK
$37.49
$4.4813.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -21.50% | 40.67% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.50% | 40.67% | -- | -- | -- |
| Operating Income | 21.50% | -40.67% | -- | -- | -- |
| Income Before Tax | -58.48% | -40.65% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -58.48% | -40.65% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.48% | -40.65% | -- | -- | -- |
| EBIT | 21.50% | -40.67% | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -39.46% | -29.02% | -- | -- | -- |
| Normalized Basic EPS | -39.54% | -29.03% | -- | -- | -- |
| EPS Diluted | -39.46% | -29.02% | -- | -- | -- |
| Normalized Diluted EPS | -39.54% | -29.03% | -- | -- | -- |
| Average Basic Shares Outstanding | -31.57% | -11.50% | -- | -- | -- |
| Average Diluted Shares Outstanding | -31.57% | -11.50% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |